🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial was originally designed and powered to compare biomarker modulat...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2005-11
Trial ID
NCT01515137
Treatments Being Tested
This phase II trial is studying how well giving sulindac together with tamo...
Status
Completed
Location
Children's Oncology Group
Start Date
2004-02
Trial ID
NCT00068419
Treatments Being Tested
This randomized phase III trial is studying eflornithine and sulindac to se...
Status
Completed
Location
University of California Medical Center At Irvine-Orange Campus
Start Date
1998-07
Trial ID
NCT00118365
Treatments Being Tested
Taxotere has been approved by the FDA and is considered a standard treatmen...
Status
Completed
Location
Birmingham Hematology Oncology Associates
Start Date
2001-04
Trial ID
NCT00085826
Treatments Being Tested
This research study is a Phase II clinical trial. Phase II clinical trials ...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2014-01
Trial ID
NCT01843179
Treatments Being Tested
The main purpose of this research study is to collect information to learn ...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2006-10
Trial ID
NCT00392665
Treatments Being Tested
Rational for conducting the study: Periprosthetic joint infection (PJI) is ...
Status
Active Not Recruiting
Location
Umeå University Hospital
Start Date
2022-01-01
Trial ID
NCT05164081
This study is a multicenter, randomized, double-blind, placebo-controlled c...
Status
Recruiting
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University
Start Date
2025-01-20
Trial ID
NCT06693362
Treatments Being Tested
The investigators hypothesize that the combination of eflornithine and suli...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2013-08-23
Trial ID
NCT01349881
The purpose of this study is to determine the effects of 2 drugs (sulindac ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT01636128
Treatments Being Tested